午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
Guangzhou Viocon Pharmaceutical Technology Co., Ltd
Firmenname:
Guangzhou Viocon Pharmaceutical Technology Co., Ltd
Telefon:
-
E-Mail:
pengguizi@cti-cert.com
Nationalit?t:
China
URL:
Produkte insgesamt:
362
1
2
3
4
Produktkatalog
Atrasentan? Impurity15
Atrasentan Impurity 09
Trametinib Impurity 12
871700-24-2
C18H15FIN3O4
Atrasentan Impurity 27
Atrasentan Impurity 19
Baricitinib Impurity 1
C15H15N7O2S
Quisinostat Impurity6
Dexpanthenol Impurity1
α-Hydroxy-β,β-dimethyl-γ-butyrolacton
599-04-2
C6H10O3
Baricitinib Impurity 2
Dexpanthenol Impurity3
Panthenol , DL-Form
C9H19NO4
Dexpanthenol Impurity2
Dexpanthenol
81-13-0
C9H19NO4
Atrasentan Impurity06
ethyl (2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate
1416134-48-9
C17H24N2O7
5-BROMOVERATRALDEHYDE
3-Brom-4,5-dimethoxybenzaldehyd
6948-30-7
C9H9BrO3
Trans-5-(Benzyloxyamino)piperidine-2-carboxylic acid
1501980-29-5
C13H18N2O3
Phosphorothioic acid, 0,0,0-triphenyl esters, tert-Bu derivs.
192268-65-8
TRIPHENYL PHOSPHOROTHIONATE
O,O,O-Triphenylthiophosphat
597-82-0
C18H15O3PS
Palbociclib Impurity10
Ibubinib impurity 11
Palbociclib Impurity16
Palbociclib Impurity13
Ibubinib impurity 13
Osimertinib Impurity02
2364486-23-5
C13H10ClN3
Ruxolitinib Impurity 07
Dasatinib Impurity05
Osimertinib Impurity01
51953-14-1
C4H4N2O2
METHYLENE BLUE
122965-43-9
C16H20ClN3OS
Methylene Blue
7220-79-3
C16H20ClN3OS
Palbociclib Impurity17
Osimertinib Impurity 03
448-19-1
C7H6FNO3
Ibubinib impurity 10
Osimertinib Impurity 07
2850389-35-2
Crizotinib Impurity15
877397-65-4
C8H7Cl2FO
Ibubinib impurity 09
2-(3-bromo-4,5-dimethoxyphenyl)ethan-1-aminehydrochloride
92015-18-4
C10H14BrNO2.ClH
Lapatinib Impurity 05
2172855-57-9
C55H43Cl2F2N7O6S
Crizotinib Impurity11
877397-70-1
C13H9Cl2FN2O3
Lapatinib Impurity 06
1268997-70-1
C22H21ClN4O4S
Tofacitinib Impurity02
6-Aminouracil
873-83-6
C4H5N3O2
Tofacitinib Impurity 12
2227199-28-0
C14H19N5O
Tofacitinib Impurity 07
2504210-38-0
C19H22N8
Tofacitinib Impurity01
3680-71-5
C6H5N3O
Tofacitinib Impurity 08
90953-01-8
C8H10N4
Tofacitinib Impurity 03
39929-79-8
C6H5N3O2
Osimertinib Impurity 14
2919324-18-6
C56H66N14O4
Atrasentan Impurity 02
Lapatinib Impurity 04
633370-23-7
C29H27FN4O4S
Osimertinib Impurity11
1421373-99-0
C27H31N7O2
Atrasentan Impurity 08
Ibubinib impurity 05
Crizotinib Impurity12
877397-71-2
C13H11Cl2FN2O
Atrasentan Impurity 22
Atrasentan Impurity 21
Osimertinib Impurity 12
1975982-94-5
C28H33N7O3
Lapatinib Impurity03
231277-91-1
C29H27ClN4O4S
Osimertinib Impurity 13
2227103-37-7
C27H33N7O2
Crizotinib Impurity14
877399-00-3
C13H10BrCl2FN2O
Quisinostat Impurity4
Osimertinib Impurity04
C22H24N6O
Trametinib Impurity 01
Atrasentan Impurity 23
Atrasentan Impurity 26
34066-46-1
C18H38N2O
Trametinib Impurity 18
Trametinib Impurity 10
Quisinostat Impurity5
Atrasentan Impurity 25
Trametinib Impurity 06
Trametinib Impurity 08
Atrasentan Impurity 20
Quisinostat Impurity7
Quisinostat Impurity8
Quisinostat Impurity1
Trametinib Impurity 14
Atrasentan Impurity 28
Trametinib Impurity 04
Trametinib Impurity 16
C26H23FIN5O5
Atrasentan Impurity 18
Trametinib Impurity 07
Quisinostat Impurity2
Quisinostat Impurity3
Atrasentan Impurity 24
Atrasentan Impurity 12
Atrasentan Impurity 10
Atrasentan? Impurity16
Atrasentan Impurity 13
Atrasentan Impurity 11
?Atrasentan? Impurity 17
Atrasentan? Impurity 14
Dasatinib Impurity06
Osimertinib Impurity 05
2213409-62-0
C23H20FN5O2
Crizotinib Impurity 13
2509276-79-1
C13H11Cl2FN2O2
Lapatinib Impurity 02
1026818-86-9
C29H26ClFN4O4S
Tofacitinib Impurity 11
2097982-05-1
C13 H19 N5
Lapatinib Impurity07
320337-48-2
C26H19ClFN3O3
(R)-(+)-Verapamilic Acid
38175-99-4
C16H21NO4
Osimertinib Impurity06
Crizotinib Impurity07
Osimertinib Impurity 09
Crizotinib Impurity 01
877399-51-4
C26H30Cl2FN5O3
Crizotinib Impurity06
1428476-74-7
C23H24Cl2FN5O2
1
2
3
4
Copyright 2019 ? ChemicalBook. All rights reserved